AngioDynamics Inc. (ANGO)
undefined
undefined%
At close: undefined
9.27
0.00%
After-hours Jan 06, 2025, 04:00 PM EST

Company Description

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.

The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.

It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits.

In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency.

Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names.

It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships.

The company was founded in 1988 and is headquartered in Latham, New York.

AngioDynamics Inc.
AngioDynamics Inc. logo
Country United States
IPO Date Jun 1, 2004
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 748
CEO James C. Clemmer

Contact Details

Address:
14 Plaza Drive
Latham, New York
United States
Website https://www.angiodynamics.com

Stock Details

Ticker Symbol ANGO
Exchange NASDAQ
Fiscal Year June - May
Reporting Currency USD
CIK Code 0001275187
CUSIP Number 03475V101
ISIN Number US03475V1017
Employer ID 11-3146460
SIC Code 3841

Key Executives

Name Position
James C. Clemmer Chief Executive Officer, President & Director
Stephen A. Trowbridge Executive Vice President & Chief Financial Officer
Benjamin H. Davis Senior Vice President of Business Development & Strategy
Chad T. Campbell Senior Vice President and GM of Global Vascular Access & Oncology Business Unit
Juan Carlos Serna Senior Vice President of Scientific & Clinical Affairs
Kim L. Seabury Senior Vice President of Information Technology
Laura Piccinini Senior Vice President & GM of Endovascular Therapies and International
Marna I. Bronfen-Moore Senior Vice President of Human Resources
Saleem M. Cheeks Vice President of Communications
Warren G. Nighan Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain

Latest SEC Filings

Date Type Title
Dec 04, 2024 4 Filing
Dec 04, 2024 3 Filing
Nov 15, 2024 8-K Current Report
Nov 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 23, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 10, 2024 4 Filing
Oct 08, 2024 4 Filing
Oct 08, 2024 4 Filing
Oct 03, 2024 10-Q Quarterly Report
Oct 03, 2024 8-K Current Report